Contact: Jenni Glenn Gingery jgingery@endo-society.org 301-941-0240 The Endocrine Society Study results suggest combination treatments may be needed to stop bone loss, fuel growth Chevy Chase, MD––Although the drug zoledronic acid slows bone loss in osteoporosis patients, it also boosts levels… Read More ›
Zoledronic acid
New task force report on bisphosphonate use and atypical femur fractures in osteoporosis patients: 94 percent (291) of patients had taken the drugs, most for more than five years
2010 study posted for filing Contact: Sara Knoll sknoll@burnesscommunications.com 301-652-1558 Burness Communications Expert panel calls for additional product labeling, international patient registry Washington, DC, SEPTEMBER 14, 2010– A widely prescribed class of drugs is highly effective in reducing common bone… Read More ›
Engineering Evil 